Found 747 matching trials
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs PHASE2 The goal of this prospective study is to explore the safety and preliminary...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC PHASE2 This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Show More Location
Multiple Locations
Learn More & Join Trial
Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC NA Hepatocellular carcinoma (HCC) is a leading global cause of cancer-related ...
Show More Location
Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer PHASE1 This prospective, single-arm study is conducted to investigate the safety a...
Show More Location
West China Hospital of Sichuan University
Learn More & Join Trial
A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection PHASE3 To compare the impact on recurrence risk of adjuvant Sintilimab (a recombin...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Perioperative Therapy for Hepatocellular Carcinoma PHASE2 This study aims to observe and evaluate the efficacy and safety of the peri...
Show More Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Safety and Efficacy of Leucine-Restricted Diet Combined With Neoadjuvant Chemotherapy and Immunotherapy in Gastric Cancer PHASE2 Consistent with previous literature, the investigators postulate that a leu...
Show More Location
Qilu Hospital of Shandong University
Learn More & Join Trial
Phase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer Patients PHASE2 This is a prospective, Single arm Phase II trial. Patients were eligible to...
Show More Location
Chinese Academy of Medical Sciences
Learn More & Join Trial
Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation NA This is an open, one-arm study to evaluate the safety and efficacy of mRNA ...
Show More Location
Multiple Locations
Learn More & Join Trial
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer PHASE2 This is a single-arm, phase II study aiming to evaluate the feasibility and...
Show More Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial